UPDATED Aug 16, 2025
Discover small cap French Pharmaceuticals & Biotech companies that are on the CAC. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ALNEV | €0.86 | 10.2% | -100.0% | €409.9k | n/a | PB0.02x | n/a | n/a | ||
PHXM | €0.10 | 0% | -94.5% | €1.0m | €4.90 | PB0.04x | E17.1% | n/a | ||
GNRO | €0.035 | 15.1% | -49.7% | €1.0m | n/a | n/a | n/a | n/a | ||
ALINT | €0.32 | 11.9% | -50.4% | €2.1m | n/a | PB1.2x | n/a | n/a | ||
MLCOT | €0.22 | 4.8% | 856.5% | €2.9m | n/a | PE139.9x | n/a | n/a | ||
ALBPS | €0.18 | 0.2% | -65.2% | €4.2m | n/a | PE-0.4x | n/a | n/a | ||
ALQGC | €0.072 | 0% | -9.0% | €5.0m | n/a | PS503305.9x | n/a | n/a | ||
ALTAO | €0.0084 | 2.4% | -25.0% | €6.9m | n/a | PS11.2x | n/a | n/a | ||
ALOPM | €0.40 | -7.1% | -63.1% | €7.2m | €2.00 | PE1.1x | E41.5% | n/a | ||
ALTME | €0.11 | -1.1% | -26.7% | €10.4m | n/a | PS544.9x | n/a | n/a | ||
ALPAT | €9.36 | 1.1% | -42.6% | €10.5m | n/a | PE11.2x | n/a | n/a | ||
ALVIO | €0.065 | 0.3% | -23.3% | €11.8m | n/a | PS6.6x | n/a | n/a | ||
ALPRE | €3.20 | -5.3% | -34.2% | €12.1m | €20.92 | PS24.5x | S52.4% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
ALVAL | €0.90 | 8.4% | -36.4% | €14.3m | €3.00 | PS81.2x | E42.7% | n/a | ||
ALDVI | €1.19 | 0.7% | 19.9% | €16.9m | €4.00 | PS3.2x | E70.6% | n/a | ||
POXEL | €0.33 | -40.3% | -50.6% | €18.0m | n/a | PS8.2x | n/a | n/a | ||
ALNFL | €1.44 | 8.6% | -31.4% | €18.2m | €3.90 | PS396696.3x | n/a | n/a | ||
AELIS | €1.46 | 11.5% | -87.7% | €19.8m | €11.00 | PS3.6x | E106.9% | n/a | ||
ALTHX | €2.55 | 15.9% | 325.0% | €21.8m | €4.90 | PS9.5x | n/a | n/a | ||
SIGHT | €0.16 | 12.9% | -54.6% | €24.2m | n/a | PS9.2x | E-43.5% | n/a | ||
ALGEN | €3.05 | -2.2% | -23.6% | €28.1m | n/a | PE15.4x | n/a | n/a | ||
MLINA | €3.82 | n/a | n/a | €28.7m | n/a | n/a | n/a | n/a | ||
ALNOV | €0.47 | 6.8% | -58.1% | €33.4m | n/a | PS1.5x | n/a | n/a |